Javid Moslehi, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address555 Mission Bay Blvd South, #212
San Francisco CA 94158
Phone415-502-3119
Emailjavid.moslehi@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns Hopkins University, Baltimore, MDBA06/1996Biology
    University of Connecticut, Farmington, CTMD06/2001Medicine
    Johns Hopkins Hospital, Baltimore, MD06/2004Residency, Internal Medicine
    Brigham and Women's Hospital, Boston, MA06/2007Fellowship, Cardiology
    Dana-Farber Cancer Institute, Boston, MA05/2014Post-Doctoral Fellowship, Oncology
    Collapse Awards and Honors
    Brigham and Women's Hospital, Harvard Medical School2009Thomas Smith Award in Heart Failure Research
    Stanley J. Sarnoff Cardiovascular Research Foundation2016Alumni Achievement Award
    Vanderbilt University2016Biomedical Science Impact Award
    American Society of Clinical Investigation (ASCI)2020Elected Member
    UCSF2021Inaugural Holder of the William Grossman Distinguished Professorship in Cardiology
    Association of American Physicians (AAP)2024Elected Member

    Collapse Overview 
    Collapse Overview
    CLINICAL INTERESTS:
    Cardio-Oncology, Cardio-Immunology

    RESEARCH INTERESTS:
    I am a cardiologist and myocyte biologist. My clinical focus is cardio-oncology and cardio-immunology. My clinical interests overlap with my laboratory focus, where we are investigating the mechanistic underpinnings of cardiovascular sequelae of novel targeted and immune-based cancer therapies.

    Since 2016, a major focus of my clinical and research program has been the interaction between the cardiovascular and immune systems. Our group initially described a novel clinical syndrome of fulminant myocarditis that arises from (ICI) immune checkpoint inhibitors (Johnson et al, NEJM, 2016). We further defined the clinical characteristics of ICI-associated myocarditis (Moslehi et al, Lancet, 2018) and showed that cardiovascular sequelae of ICI include pericarditis, vasculitis and arrhythmias (Salem et al, Lancet Oncology, 2018). My laboratory has generated mouse models that recapitulate these novel immune-based clinical syndromes which have provided insights into new diagnostic and treatment strategies for these complications (Bonaca et al, Circulation, 2019; Salem et al, NEJM, 2019; Wei et al, Cancer Discovery, 2021). My interest in this space has recently expanded to other inflammatory cardiomyopathies, including giant cell myocarditis, acute cellular rejection (ACR) following cardiac transplantation, and other forms of myocarditis. Our group is further investigating the how the immune system can be harnessed to treat heart disease.

    Collapse Research 
    Collapse Research Activities and Funding
    Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
    NIH R01HL155990May 1, 2021 - Apr 30, 2026
    Role: Principal Investigator
    Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
    NIH R01HL156021May 1, 2021 - Apr 30, 2026
    Role: Principal Investigator
    Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
    NIH R01HL141466Aug 1, 2019 - May 31, 2024
    Role: Principal Investigator
    Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension
    NIH R56HL141466Sep 15, 2018 - Aug 31, 2019
    Role: Principal Investigator
    A Functional Role for Prolyl Hydroxylases (PHDs) in Cardiomyopathy
    NIH K08HL097031Sep 30, 2009 - Jun 30, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective. EClinicalMedicine. 2024 Apr; 70:102536. Gougis P, Jochum F, Abbar B, Dumas E, Bihan K, Lebrun-Vignes B, Moslehi J, Spano JP, Laas E, Hotton J, Reyal F, Hamy AS, Salem JE. PMID: 38560659; PMCID: PMC10981010.
      View in: PubMed   Mentions:
    2. Cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib. Blood Adv. 2024 Mar 19. Moslehi JJ, Furman RR, Tam CS, Salem JE, Flowers CR, Cohen A, Zhang M, Zhang J, Chen L, Ma H, Brown JR. PMID: 38502198.
      View in: PubMed   Mentions:    Fields:    
    3. B-Cell Immune Checkpoints Come of Age in Cardio-oncology. Circ Res. 2024 Mar; 134(5):569-571. Gutierrez A, Moslehi JJ. PMID: 38422182.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Ponatinib-Induced Cardiomyocyte Toxicity: Dark Side of the Integrated Stress Response. Circ Res. 2024 Mar; 134(5):502-504. Liang FG, Moslehi J, Kitsis RN. PMID: 38422183; PMCID: PMC10906736.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Genetic interleukin-6 receptor variant is not associated with rejection and mortality after heart transplantation. J Card Fail. 2024 Feb 15. Amancherla K, Schlendorf KH, Vlasschaert C, Lowery BD, Wells QS, See SB, Zorn E, Colombo PC, Reilly MP, Lindenfeld J, Uriel N, Shah RV, Freedman JE, Moslehi J, Bick AG, Clerkin K. PMID: 38367904.
      View in: PubMed   Mentions:    Fields:    
    6. Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nat Med. 2024 Jan 03. Fenioux C, Abbar B, Boussouar S, Bretagne M, Power JR, Moslehi JJ, Gougis P, Amelin D, Dechartres A, Lehmann LH, Courand PY, Cautela J, Alexandre J, Procureur A, Rozes A, Leonard-Louis S, Qin J, International ICI-Myocarditis Registry, Cheynier R, Charmeteau-De Muylder B, Redheuil A, Tubach F, Cadranel J, Milon A, Ederhy S, Similowski T, Johnson DB, Pizzo I, Catalan T, Benveniste O, Hayek SS, Allenbach Y, Rosenzwajg M, Dolladille C, Salem JE. PMID: 38172633.
      View in: PubMed   Mentions:    Fields:    
    7. Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nat Med. 2023 Dec; 29(12):3268. Fenioux C, Abbar B, Boussouar S, Bretagne M, Power JR, Moslehi JJ, Gougis P, Amelin D, Dechartres A, Lehmann LH, Courand PY, Cautela J, Alexandre J, Procureur A, Rozes A, Leonard-Louis S, Qin J, International ICI-Myocarditis Registry, Cheynier R, Charmeteau-De Muylder B, Redheuil A, Tubach F, Cadranel J, Milon A, Ederhy S, Similowski T, Johnson DB, Pizzo I, Catalan T, Benveniste O, Hayek SS, Allenbach Y, Rosenzwajg M, Dolladille C, Salem JE. PMID: 38012317.
      View in: PubMed   Mentions:    Fields:    
    8. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nat Med. 2023 Dec; 29(12):3100-3110. Fenioux C, Abbar B, Boussouar S, Bretagne M, Power JR, Moslehi JJ, Gougis P, Amelin D, Dechartres A, Lehmann LH, Courand PY, Cautela J, Alexandre J, Procureur A, Rozes A, Leonard-Louis S, Qin J, International ICI-Myocarditis Registry, Cheynier R, Charmeteau-De Muylder B, Redheuil A, Tubach F, Cadranel J, Milon A, Ederhy S, Similowski T, Johnson DB, Pizzo I, Catalan T, Benveniste O, Hayek SS, Allenbach Y, Rosenzwajg M, Dolladille C, Salem JE. PMID: 37884625.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both. Oncologist. 2023 10 03; 28(10):e977-e980. Bonaca MP, Moslehi JJ, Ledermann JA, Michelon E, Wei C, Moran M, Monk BJ, Pujade-Lauraine E. PMID: 37665777; PMCID: PMC10546816.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. Circulation. 2024 01 02; 149(1):48-66. Ma P, Liu J, Qin J, Lai L, Heo GS, Luehmann H, Sultan D, Bredemeyer A, Bajapa G, Feng G, Jimenez J, He R, Parks A, Amrute J, Villanueva A, Liu Y, Lin CY, Mack M, Amancherla K, Moslehi J, Lavine KJ. PMID: 37746718.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    11. CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis. Circ Res. 2023 08 04; 133(4):298-312. Régnier P, Le Joncour A, Maciejewski-Duval A, Darrasse-Jèze G, Dolladille C, Meijers WC, Bastarache L, Fouret P, Bruneval P, Arbaretaz F, Sayetta C, Márquez A, Rosenzwajg M, Klatzmann D, Cacoub P, Moslehi JJ, Salem JE, Saadoun D. PMID: 37435729.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Immune Checkpoint Inhibitors' Effects on Calcified Aortic Plaques in Melanoma Survivors: A Retrospective Cohort Study. JACC CardioOncol. 2023 Aug; 5(4):536-538. Turker I, Nair S, Terry JG, Huang S, Carr JJ, Moslehi JJ, Gupta DK, Alexander MR, Johnson DB. PMID: 37614587; PMCID: PMC10443105.
      View in: PubMed   Mentions: 2  
    13. Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2023 08 08; 148(6):473-486. Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, Stein F, Bretagne M, Ederhy S, Fenioux C, Hamwy O, Funck-Brentano E, Romano E, Pieroni L, Münster JP, Allenbach Y, Anquetil C, Leonard-Louis S, Palaskas NL, Hayek SS, Katus HA, Giannitsis E, Frey N, Kaya Z, Moslehi J, Prifti E, Salem JE. PMID: 37317858; PMCID: PMC10527069.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    14. Clonal hematopoiesis of indeterminate potential and outcomes after heart transplantation: A multicenter study. Am J Transplant. 2023 08; 23(8):1256-1263. Amancherla K, Schlendorf KH, Vlasschaert C, Lowery BD, Wells QS, See SB, Zorn E, Colombo PC, Reilly MP, Lindenfeld J, Uriel N, Freedman JE, Shah RV, Moslehi J, Bick AG, Clerkin K. PMID: 37156299; PMCID: PMC10524751.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discov. 2023 05 04; 13(5):1100-1115. Salem JE, Bretagne M, Abbar B, Leonard-Louis S, Ederhy S, Redheuil A, Boussouar S, Nguyen LS, Procureur A, Stein F, Fenioux C, Devos P, Gougis P, Dres M, Demoule A, Psimaras D, Lenglet T, Maisonobe T, De Chambrun MP, Hekimian G, Straus C, Gonzalez-Bermejo J, Klatzmann D, Rigolet A, Guillaume-Jugnot P, Champtiaux N, Benveniste O, Weiss N, Saheb S, Rouvier P, Plu I, Gandjbakhch E, Kerneis M, Hammoudi N, Zahr N, Llontop C, Morelot-Panzini C, Lehmann L, Qin J, Moslehi JJ, Rosenzwajg M, Similowski T, Allenbach Y. PMID: 36815259.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    16. A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma. Am Soc Clin Oncol Educ Book. 2023 May; 43:e390594. Chen YC, Jaffer M, Zhou L, Moslehi J, Forsyth PA, Fecher LA. PMID: 37229626.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. bioRxiv. 2023 Apr 29. Ma P, Liu J, Qin J, Lai L, Heo GS, Luehmann H, Sultan D, Bredemeyer A, Bajapa G, Feng G, Jimenez J, Parks A, Amrute J, Villanueva A, Liu Y, Lin CY, Mack M, Amancherla K, Moslehi J, Lavine KJ. PMID: 37162929; PMCID: PMC10168426.
      View in: PubMed   Mentions:
    18. Circulating immune checkpoints predict heart failure outcomes. ESC Heart Fail. 2023 08; 10(4):2330-2337. Screever EM, Yousif LIE, Moslehi JJ, Salem JE, Voors AA, Silljé HHW, de Boer RA, Meijers WC. PMID: 37186066; PMCID: PMC10375122.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    19. The next big questions in cancer research. Cell. 2023 04 13; 186(8):1523-1527. Loi S, Settleman J, Joyce JA, Pramesh CS, Bernards R, Fan J, Merchant JL, Moslehi J, Sellers WR. PMID: 37059060.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA. 2023 04 04; 329(13):1098-1113. Ammirati E, Moslehi JJ. PMID: 37014337.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    21. Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology. J Immunother Cancer. 2023 03; 11(3). Naidoo J, Murphy C, Atkins MB, Brahmer JR, Champiat S, Feltquate D, Krug LM, Moslehi J, Pietanza MC, Riemer J, Robert C, Sharon E, Suarez-Almazor ME, Suresh K, Turner M, Weber J, Cappelli LC. PMID: 37001909; PMCID: PMC10069596.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. Addressing cardiovascular complications of BTK inhibitors. Clin Adv Hematol Oncol. 2023 02; 21(2):94-96. Moslehi J. PMID: 36780475.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice Review. J Gastrointest Cancer. 2023 Dec; 54(4):1102-1115. Chan H, Savoie MB, Munir A, Moslehi J, Anwar M, Laffan A, Rowen T, Salmon R, Varma M, Van Loon K. PMID: 36622517; PMCID: PMC10754749.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions. JACC CardioOncol. 2022 Dec; 4(5):704-707. Moslehi J, Salem JE. PMID: 36636442; PMCID: PMC9830216.
      View in: PubMed   Mentions: 9  
    25. Single-Nuclear RNA Sequencing of Endomyocardial Biopsies Identifies Persistence of Donor-Recipient Chimerism With Distinct Signatures in Severe Cardiac Allograft Vasculopathy. Circ Heart Fail. 2023 01; 16(1):e010119. Amancherla K, Qin J, Hulke ML, Pfeiffer RD, Agrawal V, Sheng Q, Xu Y, Schlendorf KH, Lindenfeld J, Shah RV, Freedman JE, Tucker NR, Moslehi J. PMID: 36524467; PMCID: PMC9852032.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. T cells specific for α-myosin drive immunotherapy-related myocarditis. Nature. 2022 11; 611(7937):818-826. Axelrod ML, Meijers WC, Screever EM, Qin J, Carroll MG, Sun X, Tannous E, Zhang Y, Sugiura A, Taylor BC, Hanna A, Zhang S, Amancherla K, Tai W, Wright JJ, Wei SC, Opalenik SR, Toren AL, Rathmell JC, Ferrell PB, Phillips EJ, Mallal S, Johnson DB, Allison JP, Moslehi JJ, Balko JM. PMID: 36385524; PMCID: PMC9930174.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCells
    27. Heightened apoptotic priming of vascular cells across tissues and life span predisposes them to cancer therapy-induced toxicities. Sci Adv. 2022 11 11; 8(45):eabn6579. Spetz JKE, Florido MHC, Fraser CS, Qin X, Choiniere J, Yu SJ, Singh R, Friesen M, Rubin LL, Salem JE, Moslehi JJ, Sarosiek KA. PMID: 36351019; PMCID: PMC9645721.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    28. Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis. Sci Transl Med. 2022 11 02; 14(669):eabo1981. Zhang Y, Sun C, Li Y, Qin J, Amancherla K, Jing Y, Hu Q, Liang K, Zhang Z, Ye Y, Huang LA, Nguyen TK, Egranov SD, Zhao Z, Wu A, Xi Y, Yao J, Hung MC, Calin GA, Cheng J, Lim B, Lehmann LH, Salem JE, Johnson DB, Curran MA, Yu D, Han L, Darabi R, Yang L, Moslehi JJ, Lin C. PMID: 36322628; PMCID: PMC9809130.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    29. Reply to S. Rossi et al and P. Palassin et al. J Clin Oncol. 2023 02 10; 41(5):1157-1158. Naqash AR, Johnson DB, Moslehi JJ, Sharon E. PMID: 36318738; PMCID: PMC9928682.
      View in: PubMed   Mentions:    Fields:    
    30. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022 11 01; 43(41):4229-4361. Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH, ESC Scientific Document Group. PMID: 36017568.
      View in: PubMed   Mentions: 358     Fields:    Translation:Humans
    31. A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer Surgery. Biol Res Nurs. 2023 04; 25(2):289-299. Sheng Y, Carpenter JS, Smith BJ, Paul SM, Melisko M, Moslehi J, Levine JD, Conley YP, Kober KM, Miaskowski C. PMID: 36255356; PMCID: PMC10236444.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging. 2022 09 10; 23(10):e333-e465. Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH, ESC Scientific Document Group. PMID: 36017575.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    33. Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carcinoma. J Heart Lung Transplant. 2022 12; 41(12):1860-1864. Tai W, Doolittle GC, Shah Z, Atkinson JB, Russell E, Genton RE, Moslehi JJ, Porter CB. PMID: 36220718; PMCID: PMC10166596.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. Eur J Cancer. 2022 12; 177:197-205. Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Itzhaki Ben Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE, International ICI-myocarditis registry contributors. PMID: 36030143; PMCID: PMC10165738.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism. J Clin Invest. 2022 07 01; 132(13). Szczepaniak P, Siedlinski M, Hodorowicz-Zaniewska D, Nosalski R, Mikolajczyk TP, Dobosz AM, Dikalova A, Dikalov S, Streb J, Gara K, Basta P, Krolczyk J, Sulicka-Grodzicka J, Jozefczuk E, Dziewulska A, Saju B, Laksa I, Chen W, Dormer J, Tomaszewski M, Maffia P, Czesnikiewicz-Guzik M, Crea F, Dobrzyn A, Moslehi J, Grodzicki T, Harrison DG, Guzik TJ. PMID: 35617030; PMCID: PMC9246378.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    36. Reply to S. Tan et al. J Clin Oncol. 2022 10 10; 40(29):3469. Rini BI, Moslehi JJ, Hariharan S. PMID: 35709468.
      View in: PubMed   Mentions: 1     Fields:    
    37. Expanding the Therapeutic World of Tryptophan Metabolism. Circulation. 2022 06 14; 145(24):1799-1802. Wyant GA, Moslehi J. PMID: 35696459.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. AGS and NIA bench-to bedside conference summary: Cancer and cardiovascular disease. J Am Geriatr Soc. 2022 10; 70(10):2764-2774. Mohile S, Blaum CS, Abadir PM, Dale W, Forman DE, Fung C, Holmes HM, Moslehi J, Mustian KM, Rich MW, Whitson HE. PMID: 35689461; PMCID: PMC9588510.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. J Clin Oncol. 2022 10 10; 40(29):3439-3452. Naqash AR, Moey MYY, Cherie Tan XW, Laharwal M, Hill V, Moka N, Finnigan S, Murray J, Johnson DB, Moslehi JJ, Sharon E. PMID: 35658474; PMCID: PMC10166352.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    40. Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients. Haematologica. 2022 06 01; 107(6):1335-1346. Brown JR, Byrd JC, Ghia P, Sharman JP, Hillmen P, Stephens DM, Sun C, Jurczak W, Pagel JM, Ferrajoli A, Patel P, Tao L, Kuptsova-Clarkson N, Moslehi J, Furman RR. PMID: 34587719; PMCID: PMC9152976.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis. Arch Cardiovasc Dis. 2022 May; 115(5):315-330. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek SS, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehmann LH, Ederhy S, Moslehi J, Salem JE, International ICI-Myocarditis Registry. PMID: 35595646.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer. Nat Rev Cardiol. 2022 06; 19(6):414-425. Karlstaedt A, Moslehi J, de Boer RA. PMID: 35440740; PMCID: PMC10112835.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    43. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. J Immunother Cancer. 2022 04; 10(4). Nguyen LS, Bretagne M, Arrondeau J, Zahr N, Ederhy S, Abbar B, Pinna B, Allenbach Y, Mira JP, Moslehi J, Rosenzwajg M, Salem JE. PMID: 35383117; PMCID: PMC8984056.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    44. Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis. Front Med (Lausanne). 2022; 9:838564. Ammirati E, Bizzi E, Veronese G, Groh M, Van de Heyning CM, Lehtonen J, Pineton de Chambrun M, Cereda A, Picchi C, Trotta L, Moslehi JJ, Brucato A. PMID: 35350578; PMCID: PMC8958011.
      View in: PubMed   Mentions: 12  
    45. Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial. J Clin Oncol. 2022 06 10; 40(17):1929-1938. Rini BI, Moslehi JJ, Bonaca M, Schmidinger M, Albiges L, Choueiri TK, Motzer RJ, Atkins MB, Haanen J, Mariani M, Wang J, Hariharan S, Larkin J. PMID: 35239416; PMCID: PMC9177241.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    46. Sex-Specific Cardiovascular Risks of Cancer and Its Therapies. Circ Res. 2022 02 18; 130(4):632-651. Wilcox NS, Rotz SJ, Mullen M, Song EJ, Ky Hamilton B, Moslehi J, Armenian SH, Wu JC, Rhee JW, Ky B. PMID: 35175846; PMCID: PMC8915444.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis. Arch Cardiovasc Dis. 2022 Feb; 115(2):114-116. Ederhy S, Devos P, Pinna B, Funck-Brentano E, Abbar B, Fenioux C, Cohen AA, Moslehi J, Bretagne M, Allenbach Y, Kharroubi D, Salem JE. PMID: 35120869.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat Rev Clin Oncol. 2022 04; 19(4):254-267. Johnson DB, Nebhan CA, Moslehi JJ, Balko JM. PMID: 35082367; PMCID: PMC8790946.
      View in: PubMed   Mentions: 203     Fields:    Translation:Humans
    49. Harnessing big data to characterize immune-related adverse events. Nat Rev Clin Oncol. 2022 04; 19(4):269-280. Jing Y, Yang J, Johnson DB, Moslehi JJ, Han L. PMID: 35039679.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    50. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022 01 10; 13(1):25. Nguyen LS, Cooper LT, Kerneis M, Funck-Brentano C, Silvain J, Brechot N, Hekimian G, Ammirati E, Ben M'Barek B, Redheuil A, Gandjbakhch E, Bihan K, Lebrun-Vignes B, Ederhy S, Dolladille C, Moslehi JJ, Salem JE. PMID: 35013204; PMCID: PMC8748719.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    51. Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association. Circulation. 2021 12 21; 144(25):e551-e563. Zaha VG, Hayek SS, Alexander KM, Beckie TM, Hundley WG, Kondapalli L, Ky B, Leger KJ, Meijers WC, Moslehi JJ, Shah SH. PMID: 34753300.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    52. Editorial: Recent Advances in Cardiotoxicity Testing. Front Pharmacol. 2021; 12:798189. Mohamed TMA, Moslehi J, Satin J. PMID: 34819868; PMCID: PMC8606750.
      View in: PubMed   Mentions:
    53. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2021 11 02; 144(18):1521-1523. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek S, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehman L, Ederhy S, Moslehi J, Salem JE, International ICI-Myocarditis Registry†. PMID: 34723640; PMCID: PMC8567307.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    54. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol. 2021 11 01; 6(11):1329-1337. Lehmann LH, Cautela J, Palaskas N, Baik AH, Meijers WC, Allenbach Y, Alexandre J, Rassaf T, Müller OJ, Aras M, Asnani AH, Deswal A, Laufer-Perl M, Thuny F, Kerneis M, Hayek SS, Ederhy S, Salem JE, Moslehi JJ. PMID: 34232253.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    55. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study. Eur Heart J. 2021 10 07; 42(38):3915-3928. Salem JE, Nguyen LS, Moslehi JJ, Ederhy S, Lebrun-Vignes B, Roden DM, Funck-Brentano C, Gougis P. PMID: 34370839; PMCID: PMC8677441.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    56. 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis. J Immunother Cancer. 2021 10; 9(10). Boughdad S, Latifyan S, Fenwick C, Bouchaab H, Suffiotti M, Moslehi JJ, Salem JE, Schaefer N, Nicod-Lalonde M, Costes J, Perreau M, Michielin O, Peters S, Prior JO, Obeid M. PMID: 34686542; PMCID: PMC8543755.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    57. PD-L1 (Programmed Death Ligand 1) as a Marker of Acute Cellular Rejection After Heart Transplantation. Circ Heart Fail. 2021 10; 14(10):e008563. Choudhary A, Brinkley DM, Besharati S, Meijers WC, Atkinson JB, Amancherla K, Zhu Q, Huang S, Nguyen LS, Salem JE, Ammirati E, Lindenfeld J, Anders RA, Moslehi J. PMID: 34558299; PMCID: PMC8608373.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    58. High Sensitivity Troponin T and NT-proBNP in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy. Clin Hematol Int. 2021 Sep; 3(3):96-102. Hu JR, Patel A, Huang S, Su YR, Dahlman KB, Tomasek K, Zhang Y, O'Neil RT, O'Neal JF, Turker I, Johnson DB, Salem JE, Moslehi JJ, Oluwole O. PMID: 34820614; PMCID: PMC8486972.
      View in: PubMed   Mentions: 5  
    59. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database. Eur Heart J Cardiovasc Pharmacother. 2021 07 23; 7(4):312-320. Alexandre J, Salem JE, Moslehi J, Sassier M, Ropert C, Cautela J, Thuny F, Ederhy S, Cohen A, Damaj G, Vilque JP, Plane AF, Legallois D, Champ-Rigot L, Milliez P, Funck-Brentano C, Dolladille C. PMID: 32353110.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    60. Survivorship, Version 1.2021. J Natl Compr Canc Netw. 2021 06 30; 19(6):676-685. Tevaarwerk A, Denlinger CS, Sanft T, Ansbaugh SM, Armenian S, Baker KS, Broderick G, Day A, Demark-Wahnefried W, Dickinson K, Friedman DL, Ganz P, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Patel C, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Zee P, McMillian NR, Freedman-Cass DA. PMID: 34214969; PMCID: PMC8375577.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    61. Chimeric antigen receptor T-cells safety: A pharmacovigilance and meta-analysis study. Am J Hematol. 2021 09 01; 96(9):1101-1111. Dolladille C, Ederhy S, Ezine E, Choquet S, Nguyen LS, Alexandre J, Moslehi JJ, Dechartres A, Salem JE. PMID: 34057232.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. RNA-Sequencing Reveals a Distinct Transcriptomic Signature for Giant Cell Myocarditis and Identifies Novel Druggable Targets. Circ Res. 2021 07 23; 129(3):451-453. Amancherla K, Qin J, Wang Y, Axelrod ML, Balko JM, Schlendorf KH, Hoffman RD, Xu Y, Lindenfeld J, Moslehi J. PMID: 34126013; PMCID: PMC8380472.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    63. Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Circ Res. 2021 06 11; 128(12):1973-1987. Fleming MR, Xiao L, Jackson KD, Beckman JA, Barac A, Moslehi JJ. PMID: 34110908; PMCID: PMC10185355.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. Circ Res. 2021 05 28; 128(11):1780-1801. Baik AH, Oluwole OO, Johnson DB, Shah N, Salem JE, Tsai KK, Moslehi JJ. PMID: 33934609; PMCID: PMC8159878.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    65. Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. Circ Res. 2021 06 25; 129(1):e21-e34. Asnani A, Moslehi JJ, Adhikari BB, Baik AH, Beyer AM, de Boer RA, Ghigo A, Grumbach IM, Jain S, Zhu H, American Heart Association Council on Basic Cardiovascular Sciences; Cardio-Oncology Science Subcomm. PMID: 33934611; PMCID: PMC8423100.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    66. Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial. Cancer. 2021 07 01; 127(13):2213-2221. Butler SS, Mahal BA, Moslehi JJ, Nohria A, Dee EC, Makkar R, Whitbeck A, Wangoe J, Mouw KW, Nguyen PL, Muralidhar V. PMID: 33905530.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    67. High-grade heart block associated with ibrutinib therapy. HeartRhythm Case Rep. 2021 Jun; 7(6):391-394. Vartanov AR, Lampson BL, Jacobsen ED, Alyea EP, Moslehi JJ, Brown JR. PMID: 34194987; PMCID: PMC8226304.
      View in: PubMed   Mentions: 1  
    68. Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review. Eur J Cancer. 2021 05; 148:36-47. Nguyen LS, Ortuno S, Lebrun-Vignes B, Johnson DB, Moslehi JJ, Hertig A, Salem JE. PMID: 33721705.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    69. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. J Clin Invest. 2021 03 01; 131(5). Moslehi J, Lichtman AH, Sharpe AH, Galluzzi L, Kitsis RN. PMID: 33645548; PMCID: PMC7919710.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    70. Standing at the Crossroads. Cancer Cell. 2021 02 08; 39(2):123-124. Tang L, Moslehi J, Tang Y. PMID: 33561392.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Global Longitudinal Strain in Cardio-Oncology. J Am Coll Cardiol. 2021 02 02; 77(4):402-404. Moslehi JJ, Witteles RM. PMID: 33509396; PMCID: PMC8397591.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    72. Ibrutinib's Cardiotoxicity-An Opportunity for Postmarketing Regulation. JAMA Oncol. 2021 02 01; 7(2):177-178. Ratain MJ, Moslehi JJ, Lichter AS. PMID: 33237281.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    73. Implementation of Cardio-Oncology Training for Cardiology Fellows. JACC CardioOncol. 2020 Dec; 2(5):795-799. Tuzovic M, Brown SA, Yang EH, West BH, Bassi NS, Park S, Guha A, Ghosh AK, Ganatra S, Hayek SS, Moslehi J, Jahangir E. PMID: 34396296; PMCID: PMC8352041.
      View in: PubMed   Mentions: 7  
    74. Arterial Thrombotic Complications of Tyrosine Kinase Inhibitors. Arterioscler Thromb Vasc Biol. 2021 01; 41(1):3-10. Wu MD, Moslehi JJ, Lindner JR. PMID: 33275447; PMCID: PMC7770029.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    75. A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention. Cancer Discov. 2021 03; 11(3):614-625. Wei SC, Meijers WC, Axelrod ML, Anang NAS, Screever EM, Wescott EC, Johnson DB, Whitley E, Lehmann L, Courand PY, Mancuso JJ, Himmel LE, Lebrun-Vignes B, Wleklinski MJ, Knollmann BC, Srinivasan J, Li Y, Atolagbe OT, Rao X, Zhao Y, Wang J, Ehrlich LIR, Sharma P, Salem JE, Balko JM, Moslehi JJ, Allison JP. PMID: 33257470; PMCID: PMC8041233.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimals
    76. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail. 2020 11; 13(11):e007405. Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tschöpe C, Cooper LT, Camici PG. PMID: 33176455; PMCID: PMC7673642.
      View in: PubMed   Mentions: 187     Fields:    Translation:Humans
    77. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020 12; 22(12):2272-2289. de Boer RA, Hulot JS, Tocchetti CG, Aboumsallem JP, Ameri P, Anker SD, Bauersachs J, Bertero E, Coats AJS, Celutkiene J, Chioncel O, Dodion P, Eschenhagen T, Farmakis D, Bayes-Genis A, Jäger D, Jankowska EA, Kitsis RN, Konety SH, Larkin J, Lehmann L, Lenihan DJ, Maack C, Moslehi JJ, Müller OJ, Nowak-Sliwinska P, Piepoli MF, Ponikowski P, Pudil R, Rainer PP, Ruschitzka F, Sawyer D, Seferovic PM, Suter T, Thum T, van der Meer P, Van Laake LW, von Haehling S, Heymans S, Lyon AR, Backs J. PMID: 33094495; PMCID: PMC7894564.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    78. Age-Related Considerations in Cardio-Oncology. J Cardiovasc Pharmacol Ther. 2021 03; 26(2):103-113. Screever EM, Meijers WC, Moslehi JJ. PMID: 33124480.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    79. Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase. Circulation. 2020 12 22; 142(25):2443-2455. Xiao L, Salem JE, Clauss S, Hanley A, Bapat A, Hulsmans M, Iwamoto Y, Wojtkiewicz G, Cetinbas M, Schloss MJ, Tedeschi J, Lebrun-Vignes B, Lundby A, Sadreyev RI, Moslehi J, Nahrendorf M, Ellinor PT, Milan DJ. PMID: 33092403; PMCID: PMC9661397.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    80. Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study. Pharmaceuticals (Basel). 2020 Oct 21; 13(10). Hilmi M, Ederhy S, Waintraub X, Funck-Brentano C, Cohen A, Vozy A, Lebrun-Vignes B, Moslehi J, Nguyen LS, Salem JE. PMID: 33096756; PMCID: PMC7594046.
      View in: PubMed   Mentions: 10  
    81. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail. 2020 11; 22(11):1966-1983. Pudil R, Mueller C, Celutkiene J, Henriksen PA, Lenihan D, Dent S, Barac A, Stanway S, Moslehi J, Suter TM, Ky B, Šterba M, Cardinale D, Cohen-Solal A, Tocchetti CG, Farmakis D, Bergler-Klein J, Anker MS, Von Haehling S, Belenkov Y, Iakobishvili Z, Maack C, Ciardiello F, Ruschitzka F, Coats AJS, Seferovic P, Lainscak M, Piepoli MF, Chioncel O, Bax J, Hulot JS, Skouri H, Hägler-Laube ES, Asteggiano R, Fernandez TL, de Boer RA, Lyon AR. PMID: 33006257.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    82. The cancer patient and cardiology. Eur J Heart Fail. 2020 12; 22(12):2290-2309. Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G. PMID: 32809231; PMCID: PMC8278961.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    83. Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer. Urol Oncol. 2021 01; 39(1):52-62. Morgans AK, Shore N, Cope D, McNatty A, Moslehi J, Gomella L, Sartor O. PMID: 32958445.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    84. Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time? JACC CardioOncol. 2020 Sep; 2(3):503-505. Aras MA, Power JR, Moslehi JJ. PMID: 34396257; PMCID: PMC8352214.
      View in: PubMed   Mentions: 1  
    85. Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance. Annu Rev Pharmacol Toxicol. 2021 01 06; 61:85-112. Geraud A, Gougis P, Vozy A, Anquetil C, Allenbach Y, Romano E, Funck-Brentano E, Moslehi JJ, Johnson DB, Salem JE. PMID: 32871087.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    86. Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity. Toxicol Appl Pharmacol. 2020 11 01; 406:115213. Miller JM, Meki MH, Ou Q, George SA, Gams A, Abouleisa RRE, Tang XL, Ahern BM, Giridharan GA, El-Baz A, Hill BG, Satin J, Conklin DJ, Moslehi J, Bolli R, Ribeiro AJS, Efimov IR, Mohamed TMA. PMID: 32877659; PMCID: PMC7554180.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    87. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol. 2020 10; 147:74-87. Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW. PMID: 32827510; PMCID: PMC7438272.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsPHPublic Health
    88. Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients. J Am Heart Assoc. 2020 11 03; 9(21):e017736. Chen C, Wang F, Chen P, Jiang J, Cui G, Zhou N, Moroni F, Moslehi JJ, Ammirati E, Wang DW. PMID: 32807002; PMCID: PMC7763411.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    89. Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity. Circulation. 2020 08 18; 142(7):684-687. Moslehi J, Zhang Q, Moore KJ. PMID: 32804565; PMCID: PMC7436939.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    90. Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure. Annu Rev Pharmacol Toxicol. 2021 01 06; 61:113-134. Waliany S, Lee D, Witteles RM, Neal JW, Nguyen P, Davis MM, Salem JE, Wu SM, Moslehi JJ, Zhu H. PMID: 32776859.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    91. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020 11; 22(11):1945-1960. Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, Tocchetti CG, Moslehi JJ, Groarke JD, Bergler-Klein J, Khoo V, Tan LL, Anker MS, von Haehling S, Maack C, Pudil R, Barac A, Thavendiranathan P, Ky B, Neilan TG, Belenkov Y, Rosen SD, Iakobishvili Z, Sverdlov AL, Hajjar LA, Macedo AVS, Manisty C, Ciardiello F, Farmakis D, de Boer RA, Skouri H, Suter TM, Cardinale D, Witteles RM, Fradley MG, Herrmann J, Cornell RF, Wechelaker A, Mauro MJ, Milojkovic D, de Lavallade H, Ruschitzka F, Coats AJS, Seferovic PM, Chioncel O, Thum T, Bauersachs J, Andres MS, Wright DJ, López-Fernández T, Plummer C, Lenihan D. PMID: 32463967; PMCID: PMC8019326.
      View in: PubMed   Mentions: 166     Fields:    Translation:Humans
    92. Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research. Lancet Oncol. 2020 08; 21(8):e398-e404. Johnson DB, Reynolds KL, Sullivan RJ, Balko JM, Patrinely JR, Cappelli LC, Naidoo J, Moslehi JJ. PMID: 32758477.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    93. NCCN Guidelines Insights: Survivorship, Version 2.2020. J Natl Compr Canc Netw. 2020 08; 18(8):1016-1023. Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, O'Connor T, Paskett ED, Patel C, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Zee P, McMillian NR, Freedman-Cass DA. PMID: 32755975; PMCID: PMC7785060.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    94. Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy. Br J Clin Pharmacol. 2020 09; 86(9):1778-1789. Mangan BL, McAlister RK, Balko JM, Johnson DB, Moslehi JJ, Gibson A, Phillips EJ. PMID: 32543711; PMCID: PMC7444794.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    95. Impact of body composition on outcomes from anti-PD1 +/- anti-CTLA-4 treatment in melanoma. J Immunother Cancer. 2020 07; 8(2). Young AC, Quach HT, Song H, Davis EJ, Moslehi JJ, Ye F, Williams GR, Johnson DB. PMID: 32747470; PMCID: PMC7398101.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    96. Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand. Eur J Cancer. 2020 08; 135:211-220. Patrinely JR, Young AC, Quach H, Williams GR, Ye F, Fan R, Horn L, Beckermann KE, Gillaspie EA, Sosman JA, Friedman DL, Moslehi JJ, Johnson DB. PMID: 32599411; PMCID: PMC7374019.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    97. Tissue Is the Issue, Even During a Pandemic. Circulation. 2020 08 04; 142(5):423-425. Shah KS, Moslehi JJ, Fang JC. PMID: 32539523.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Inflammation begets inflammation: cancer and acute MI. Eur Heart J. 2020 06 14; 41(23):2194-2196. Kondapalli L, Moslehi J, Bonaca MP. PMID: 32068786.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    99. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities. Autoimmun Rev. 2020 Aug; 19(8):102586. Allenbach Y, Anquetil C, Manouchehri A, Benveniste O, Lambotte O, Lebrun-Vignes B, Spano JP, Ederhy S, Klatzmann D, Rosenzwajg M, Fautrel B, Cadranel J, Johnson DB, Moslehi JJ, Salem JE. PMID: 32535094.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    100. Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis. Eur Respir J. 2020 06; 55(6). Moey MYY, Gougis P, Goldschmidt V, Johnson DB, Lebrun-Vignes B, Moslehi J, Cadranel J, Salem JE. PMID: 32079644.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    101. Vascular medicine and cardio-oncology - A new, evolving clinical frontier. Vasc Med. 2020 06; 25(3):205-207. Versmissen J, Power JR, Moslehi J. PMID: 32539631; PMCID: PMC7745605.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    102. Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database. Circulation. 2020 07 21; 142(3):303-305. Nguyen LS, Dolladille C, Drici MD, Fenioux C, Alexandre J, Mira JP, Moslehi JJ, Roden DM, Funck-Brentano C, Salem JE. PMID: 32442023; PMCID: PMC7365677.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansPHPublic Health
    103. Cardiac Events Associated With Chimeric Antigen Receptor T-Cells (CAR-T): A VigiBase Perspective. J Am Coll Cardiol. 2020 05 19; 75(19):2521-2523. Salem JE, Ederhy S, Lebrun-Vignes B, Moslehi JJ. PMID: 32408984.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    104. Immune Checkpoint Inhibitor-Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis. Oncologist. 2020 08; 25(8):696-701. Grouthier V, Lebrun-Vignes B, Moey M, Johnson DB, Moslehi JJ, Salem JE, Bachelot A. PMID: 32390168; PMCID: PMC7418341.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    105. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J. 2020 05 07; 41(18):1733-1743. Zhang L, Awadalla M, Mahmood SS, Nohria A, Hassan MZO, Thuny F, Zlotoff DA, Murphy SP, Stone JR, Golden DLA, Alvi RM, Rokicki A, Jones-O'Connor M, Cohen JV, Heinzerling LM, Mulligan C, Armanious M, Barac A, Forrestal BJ, Sullivan RJ, Kwong RY, Yang EH, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Moslehi JJ, Coelho-Filho OR, Ganatra S, Rizvi MA, Sahni G, Tocchetti CG, Mercurio V, Mahmoudi M, Lawrence DP, Reynolds KL, Weinsaft JW, Baksi AJ, Ederhy S, Groarke JD, Lyon AR, Fradley MG, Thavendiranathan P, Neilan TG. PMID: 32112560; PMCID: PMC7205467.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    106. COVID-19 and immune checkpoint inhibitors: initial considerations. J Immunother Cancer. 2020 05; 8(1). Sullivan RJ, Johnson DB, Rini BI, Neilan TG, Lovly CM, Moslehi JJ, Reynolds KL. PMID: 32434790; PMCID: PMC7246104.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    107. Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy. Cancer Immunol Res. 2020 07; 8(7):851-855. Shah KP, Song H, Ye F, Moslehi JJ, Balko JM, Salem JE, Johnson DB. PMID: 32350001; PMCID: PMC7334081.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    108. Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents. Br J Haematol. 2020 08; 190(4):555-561. Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Harrell S, Rubinstein SM, Hall R, Wyatt H, Piazza G. PMID: 32314352.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    109. Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Ann Endocrinol (Paris). 2021 Jun; 82(3-4):132-133. Salem JE, Yang T, Moslehi JJ, Waintraub X, Gandjbakhch E, Bachelot A, Hidden-Lucet F, Hulot JS, Knollmann BC, Lebrun-Vignes B, Funck-Brentano C, Glazer AM, Roden DM. PMID: 32171470.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    110. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy. Circ Cardiovasc Qual Outcomes. 2020 03; 13(3):e005984. Ruddy KJ, Sangaralingham LR, Van Houten H, Nowsheen S, Sandhu N, Moslehi J, Neuman H, Jemal A, Haddad TC, Blaes AH, Villarraga HR, Thompson C, Shah ND, Herrmann J. PMID: 32106704; PMCID: PMC7101030.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    111. Response by Salem et al to Letter Regarding Article, "Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes". Circulation. 2020 02 04; 141(5):e63-e64. Salem JE, Moslehi JJ, Funck Brentano C, Roden DM. PMID: 32011925; PMCID: PMC7041671.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    112. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020 02; 31(2):171-190. Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. PMID: 31959335; PMCID: PMC8019325.
      View in: PubMed   Mentions: 283     Fields:    Translation:Humans
    113. Solid organ transplant rejection associated with immune-checkpoint inhibitors. Ann Oncol. 2020 04; 31(4):543-544. Saberianfar S, Nguyen LS, Manouchehri A, Lebrun-Vignes B, Moslehi JJ, Johnson DB, Hertig A, Salem JE. PMID: 32061451.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    114. Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses. Arterioscler Thromb Vasc Biol. 2020 03; 40(3):e55-e64. Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, Salem JE, Beckman JA, Moslehi JJ. PMID: 31969015; PMCID: PMC7047549.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    115. Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease. J Am Heart Assoc. 2020 01 21; 9(2):e013754. Aboumsallem JP, Moslehi J, de Boer RA. PMID: 31960736; PMCID: PMC7033852.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    116. Cardio-Immuno-Oncology. Circulation. 2020 01 14; 141(2):87-89. Zaha VG, Meijers WC, Moslehi J. PMID: 31928434; PMCID: PMC7192229.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    117. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020 02 11; 141(6):e69-e92. Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Ca. PMID: 31902242.
      View in: PubMed   Mentions: 196     Fields:    Translation:Humans
    118. The 2019 Nobel Prize honors fundamental discoveries in hypoxia response. J Clin Invest. 2020 01 02; 130(1):4-6. Moslehi J, Rathmell WK. PMID: 31763994; PMCID: PMC6934228.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care. Arterioscler Thromb Vasc Biol. 2020 02; 40(2):301-308. Manouchehri A, Kanu E, Mauro MJ, Aday AW, Lindner JR, Moslehi J. PMID: 31875699; PMCID: PMC6993877.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    120. Corrigendum to "Assessing cardiac safety in oncology drug development" [Am Heart J 214 (2019) 125-133]. Am Heart J. 2019 Dec; 218:133. Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF. PMID: 31806089.
      View in: PubMed   Mentions:    Fields:    
    121. Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management. Curr Cardiol Rep. 2019 11 25; 21(12):156. Ala CK, Klein AL, Moslehi JJ. PMID: 31768769.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    122. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. Urol Oncol. 2020 03; 38(3):83-93. Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. PMID: 31734020.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    123. Need for Multidisciplinary Research and Data-Driven Guidelines for the Cardiovascular Care of Patients With Cancer. JAMA. 2019 11 12; 322(18):1775-1776. Meijers WC, Moslehi JJ. PMID: 31714975; PMCID: PMC7228138.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    124. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Semin Oncol. 2019 12; 46(6):397-402. Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G. PMID: 31753424.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    125. Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study. Arch Cardiovasc Dis. 2020 Jan; 113(1):9-21. Bretagne M, Lebrun-Vignes B, Pariente A, Shaffer CM, Malouf GG, Dureau P, Potey C, Funck-Brentano C, Roden DM, Moslehi JJ, Salem JE. PMID: 31685432.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    126. Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors. Eur J Cancer. 2019 12; 123:112-115. Vozy A, De Martin E, Johnson DB, Lebrun-Vignes B, Moslehi JJ, Salem JE. PMID: 31678768.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    127. Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens. Heart Fail Rev. 2019 11; 24(6):915-925. Cadeddu Dessalvi C, Pepe A, Penna C, Gimelli A, Madonna R, Mele D, Monte I, Novo G, Nugara C, Zito C, Moslehi JJ, de Boer RA, Lyon AR, Tocchetti CG, Mercuro G. PMID: 31256318.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    128. Cancer cachexia: getting to the heart of the matter. Eur Heart J. 2019 10 21; 40(40):e17-e19. Groarke JD, Cheng S, Jones LW, Moslehi J. PMID: 24126874; PMCID: PMC6801934.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    129. Cardiovascular Toxicities Associated With Ibrutinib. J Am Coll Cardiol. 2019 10 01; 74(13):1667-1678. Salem JE, Manouchehri A, Bretagne M, Lebrun-Vignes B, Groarke JD, Johnson DB, Yang T, Reddy NM, Funck-Brentano C, Brown JR, Roden DM, Moslehi JJ. PMID: 31558250.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    130. Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy. JACC CardioOncol. 2019 Sep; 1(1):54-65. Vaduganathan M, Hirji SA, Qamar A, Bajaj N, Gupta A, Zaha V, Chandra A, Haykowsky M, Ky B, Moslehi J, Nohria A, Butler J, Pandey A. PMID: 33083790; PMCID: PMC7571368.
      View in: PubMed   Mentions: 45  
    131. Comparative Transcriptomics of Ex Vivo, Patient-Derived Endothelial Cells Reveals Novel Pathways Associated With Type 2 Diabetes Mellitus. JACC Basic Transl Sci. 2019 Sep; 4(5):567-574. Beckman JA, Doherty SP, Feldman ZB, Banks ES, Moslehi J, Jaffe IZ, Hamburg NM, Sheng Q, Brown JD. PMID: 31768474; PMCID: PMC6872769.
      View in: PubMed   Mentions: 8  
    132. Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes. Circulation. 2019 09 24; 140(13):1070-1080. Salem JE, Yang T, Moslehi JJ, Waintraub X, Gandjbakhch E, Bachelot A, Hidden-Lucet F, Hulot JS, Knollmann BC, Lebrun-Vignes B, Funck-Brentano C, Glazer AM, Roden DM. PMID: 31378084; PMCID: PMC6756939.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    133. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 07 30; 74(4):567-577. Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J, Zeiher A, Jaiswal S, Schulz C, Blankstein R, Bolton KL, Steensma D, Levine RL, Ebert BL. PMID: 31345432; PMCID: PMC6681657.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCells
    134. Fulminant Myocarditis: Evolving Diagnosis, Evolving Biology, Evolving Prognosis. J Am Coll Cardiol. 2019 07 23; 74(3):312-314. Moslehi JJ, Brinkley DM, Meijers WC. PMID: 31319913.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    135. A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis. Nat Med. 2019 08; 25(8):1243-1250. Johnson DB, McDonnell WJ, Gonzalez-Ericsson PI, Al-Rohil RN, Mobley BC, Salem JE, Wang DY, Sanchez V, Wang Y, Chastain CA, Barker K, Liang Y, Warren S, Beechem JM, Menzies AM, Tio M, Long GV, Cohen JV, Guidon AC, O'Hare M, Chandra S, Chowdhary A, Lebrun-Vignes B, Goldinger SM, Rushing EJ, Buchbinder EI, Mallal SA, Shi C, Xu Y, Moslehi JJ, Sanders ME, Sosman JA, Balko JM. PMID: 31332390; PMCID: PMC6689251.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    136. Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology Circulation. 2019 07 02; 140(2):80-91. Bonaca MP, Olenchock BA, Salem JE, Wiviott SD, Ederhy S, Cohen A, Stewart GC, Choueiri TK, Di Carli M, Allenbach Y, Kumbhani DJ, Heinzerling L, Amiri-Kordestani L, Lyon AR, Thavendiranathan P, Padera R, Lichtman A, Liu PP, Johnson DB, Moslehi J. PMID: 31390169; PMCID: PMC6779326.
      View in: PubMed   Mentions: 169     Fields:    Translation:Humans
    137. NCCN Guidelines Insights: Survivorship, Version 2.2019. J Natl Compr Canc Netw. 2019 07 01; 17(7):784-794. Sanft T, Denlinger CS, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Mooney K, Moore HCF, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peterson L, Pirl W, Rodriguez MA, Ruddy KJ, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Zee P, McMillian NR, Freedman-Cass DA. PMID: 31319383; PMCID: PMC7094216.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    138. Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis. N Engl J Med. 2019 06 13; 380(24):2377-2379. Salem JE, Allenbach Y, Vozy A, Brechot N, Johnson DB, Moslehi JJ, Kerneis M. PMID: 31189043.
      View in: PubMed   Mentions: 158     Fields:    Translation:Humans
    139. Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma. J Clin Oncol. 2019 08 01; 37(22):1946-1955. Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell SL, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O'Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Waxman A, Lenihan D. PMID: 31188726.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    140. Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs. Am J Physiol Heart Circ Physiol. 2019 07 01; 317(1):H164-H167. Beyer AM, Bonini MG, Moslehi J. PMID: 31172808; PMCID: PMC6692734.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    141. Cancer therapy-induced cardiomyopathy: can human induced pluripotent stem cell modelling help prevent it? Eur Heart J. 2019 06 07; 40(22):1764-1770. Stack JP, Moslehi J, Sayed N, Wu JC. PMID: 29377985; PMCID: PMC6554650.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    142. Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis. Int J Mol Sci. 2019 Jun 01; 20(11). Linton MF, Moslehi JJ, Babaev VR. PMID: 31159424; PMCID: PMC6600269.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimalsCells
    143. Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. J Immunother Cancer. 2019 05 22; 7(1):134. Johnson DB, Manouchehri A, Haugh AM, Quach HT, Balko JM, Lebrun-Vignes B, Mammen A, Moslehi JJ, Salem JE. PMID: 31118078; PMCID: PMC6530194.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    144. Assessing cardiac safety in oncology drug development. Am Heart J. 2019 08; 214:125-133. Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF. PMID: 31202099; PMCID: PMC7316329.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    145. Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need. Cardiovasc Res. 2019 04 15; 115(5):819-823. Moslehi J, Fujiwara K, Guzik T. PMID: 30888396.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    146. Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc Res. 2019 04 15; 115(5):854-868. Hu JR, Florido R, Lipson EJ, Naidoo J, Ardehali R, Tocchetti CG, Lyon AR, Padera RF, Johnson DB, Moslehi J. PMID: 30715219; PMCID: PMC6452314.
      View in: PubMed   Mentions: 183     Fields:    Translation:HumansAnimals
    147. Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis. Eur J Cancer. 2019 05; 113:10-13. Guerrero E, Johnson DB, Bachelot A, Lebrun-Vignes B, Moslehi JJ, Salem JE. PMID: 30954881.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    148. Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review. JAMA Cardiol. 2019 04 01; 4(4):380-387. Calvillo-Argüelles O, Jaiswal S, Shlush LI, Moslehi JJ, Schimmer A, Barac A, Thavendiranathan P. PMID: 30865214.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    149. Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 03 26; 73(11):1336-1349. Mosarla RC, Vaduganathan M, Qamar A, Moslehi J, Piazza G, Giugliano RP. PMID: 30898209; PMCID: PMC7957366.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    150. Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association. Circulation. 2019 03 26; 139(13):e579-e602. Campia U, Moslehi JJ, Amiri-Kordestani L, Barac A, Beckman JA, Chism DD, Cohen P, Groarke JD, Herrmann J, Reilly CM, Weintraub NL. PMID: 30786722; PMCID: PMC6530491.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    151. Adverse events 2.0-Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology. Eur J Cancer. 2019 05; 112:29-31. Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, McArthur G, Moslehi JJ, Neilan TG, Ribas A, Robert C, Schadendorf D, Wolchok JD, Hauschild A. PMID: 30903870.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    152. Hematologic Complications of Immune Checkpoint Inhibitors. Oncologist. 2019 05; 24(5):584-588. Davis EJ, Salem JE, Young A, Green JR, Ferrell PB, Ancell KK, Lebrun-Vignes B, Moslehi JJ, Johnson DB. PMID: 30819785; PMCID: PMC6516131.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    153. Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy. Front Oncol. 2019; 9:45. Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Harrell S, Hall R, Wyatt H, Piazza G. PMID: 30873378; PMCID: PMC6401636.
      View in: PubMed   Mentions: 9  
    154. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. J Immunother Cancer. 2019 02 22; 7(1):53. Awadalla M, Golden DLA, Mahmood SS, Alvi RM, Mercaldo ND, Hassan MZO, Banerji D, Rokicki A, Mulligan C, Murphy SPT, Jones-O'Connor M, Cohen JV, Heinzerling LM, Armanious M, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Rizvi MA, Sahni G, Lyon AR, Tocchetti CG, Mercurio V, Thuny F, Ederhy S, Mahmoudi M, Lawrence DP, Groarke JD, Nohria A, Fradley MG, Reynolds KL, Neilan TG. PMID: 30795818; PMCID: PMC6387531.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    155. The forgotten right ventricle in cardio-oncology. J Nucl Cardiol. 2020 12; 27(6):2164-2166. Jahangir E, Harinstein ME, Murthy VL, Moslehi J. PMID: 30771160; PMCID: PMC6697233.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    156. Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib. Blood. 2019 04 04; 133(14):1597-1606. Latifi Y, Moccetti F, Wu M, Xie A, Packwood W, Qi Y, Ozawa K, Shentu W, Brown E, Shirai T, McCarty OJ, Ruggeri Z, Moslehi J, Chen J, Druker BJ, López JA, Lindner JR. PMID: 30692122; PMCID: PMC6450432.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    157. Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis. Br J Haematol. 2019 02; 184(4):558-569. Brown JR, Moslehi J, Ewer MS, O'Brien SM, Ghia P, Cymbalista F, Shanafelt TD, Fraser G, Rule S, Coutre SE, Dilhuydy MS, Cramer P, Jaeger U, Dreyling M, Byrd JC, Treon S, Liu EY, Chang S, Bista A, Vempati R, Boornazian L, Valentino R, Reddy V, Mahler M, Yang H, Graef T, Burger JA. PMID: 30506764; PMCID: PMC6587776.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    158. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. JAMA Oncol. 2018 12 01; 4(12):1721-1728. Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, Menzies AM, Sosman JA, Sullivan RJ, Moslehi JJ, Johnson DB. PMID: 30242316; PMCID: PMC6440712.
      View in: PubMed   Mentions: 875     Fields:    Translation:Humans
    159. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol. 2018 12; 19(12):1579-1589. Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, Gobert A, Spano JP, Balko JM, Bonaca MP, Roden DM, Johnson DB, Moslehi JJ. PMID: 30442497; PMCID: PMC6287923.
      View in: PubMed   Mentions: 412     Fields:    Translation:Humans
    160. Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes. Diabetes Care. 2018 12; 41(12):e150-e151. Wright JJ, Salem JE, Johnson DB, Lebrun-Vignes B, Stamatouli A, Thomas JW, Herold KC, Moslehi J, Powers AC. PMID: 30305348; PMCID: PMC7301161.
      View in: PubMed   Mentions: 45     Fields:    
    161. Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife. 2018 10 03; 7. Salisbury-Ruf CT, Bertram CC, Vergeade A, Lark DS, Shi Q, Heberling ML, Fortune NL, Okoye GD, Jerome WG, Wells QS, Fessel J, Moslehi J, Chen H, Roberts LJ, Boutaud O, Gamazon ER, Zinkel SS. PMID: 30281024; PMCID: PMC6234033.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    162. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 10; 16(10):1216-1247. Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. PMID: 30323092; PMCID: PMC6438378.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansPHPublic Health
    163. Immune checkpoint inhibitors and cardiovascular toxicity. Lancet Oncol. 2018 09; 19(9):e447-e458. Lyon AR, Yousaf N, Battisti NML, Moslehi J, Larkin J. PMID: 30191849.
      View in: PubMed   Mentions: 217     Fields:    Translation:Humans
    164. Hidden Figures: Occult Intra-Cardiac Metastases in Asymptomatic Neuroendocrine Tumor Patients. J Oncol Cancer Res. 2018; 2:23-27. Das S, Pineda G, Berlin J, Hemphill B, Moslehi J, Nohria A, Fisher G. PMID: 31388651; PMCID: PMC6684348.
      View in: PubMed   Mentions: 2  
    165. Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution. Circulation. 2018 08 14; 138(7):743-745. Anquetil C, Salem JE, Lebrun-Vignes B, Johnson DB, Mammen AL, Stenzel W, Léonard-Louis S, Benveniste O, Moslehi JJ, Allenbach Y. PMID: 30359135.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    166. Reporting of immune checkpoint inhibitor-associated myocarditis - Authors' reply. Lancet. 2018 08 04; 392(10145):384-385. Moslehi JJ, Salem JE, Sosman JA, Lebrun-Vignes B, Johnson DB. PMID: 30102170.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    167. Hypogonadism as a Reversible Cause of Torsades de Pointes in Men. Circulation. 2018 07 03; 138(1):110-113. Salem JE, Waintraub X, Courtillot C, Shaffer CM, Gandjbakhch E, Maupain C, Moslehi JJ, Badilini F, Haroche J, Gougis P, Fressart V, Glazer AM, Hidden-Lucet F, Touraine P, Lebrun-Vignes B, Roden DM, Bachelot A, Funck-Brentano C. PMID: 29967236; PMCID: PMC6053686.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    168. Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention. J Clin Oncol. 2018 07 20; 36(21):2135-2144. Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B, Moslehi J, Mulrooney DA, Nathan PC, Ryan TD, van der Pal HJ, van Dalen EC, Kremer LCM. PMID: 29874141; PMCID: PMC6804893.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    169. Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action. Oncologist. 2018 08; 23(8):874-878. Neilan TG, Rothenberg ML, Amiri-Kordestani L, Sullivan RJ, Steingart RM, Gregory W, Hariharan S, Hammad TA, Lindenfeld J, Murphy MJ, Moslehi JJ, Checkpoint Inhibitor Safety Working Group. PMID: 29802220; PMCID: PMC6156187.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    170. Cardiac Toxicities in the Era of Precision Medicine: Underlying Risk Factors, Targeted Therapies, and Cardiac Biomarkers. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:764-774. Blaes AH, Thavendiranathan P, Moslehi J. PMID: 30231407.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    171. In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers. J Chem Inf Model. 2018 05 29; 58(5):943-956. Cai C, Fang J, Guo P, Wang Q, Hong H, Moslehi J, Cheng F. PMID: 29712429; PMCID: PMC5975252.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    172. Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors. Heart. 2018 11; 104(22):1859-1863. Grouthier V, Lebrun-Vignes B, Glazer AM, Touraine P, Funck-Brentano C, Pariente A, Courtillot C, Bachelot A, Roden DM, Moslehi JJ, Salem JE. PMID: 29720397; PMCID: PMC8022857.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    173. Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms. Pharmacol Ther. 2018 09; 189:89-103. Alexandre J, Moslehi JJ, Bersell KR, Funck-Brentano C, Roden DM, Salem JE. PMID: 29698683.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    174. Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase. Proc Natl Acad Sci U S A. 2018 04 17; 115(16):E3741-E3748. McBrayer SK, Olenchock BA, DiNatale GJ, Shi DD, Khanal J, Jennings RB, Novak JS, Oser MG, Robbins AK, Modiste R, Bonal D, Moslehi J, Bronson RT, Neuberg D, Nguyen QD, Signoretti S, Losman JA, Kaelin WG. PMID: 29610306; PMCID: PMC5910822.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    175. Inhibition of the α-Subunit of Phosphoinositide 3-Kinase in Heart Increases Late Sodium Current and Is Arrhythmogenic. J Pharmacol Exp Ther. 2018 06; 365(3):460-466. Yang T, Meoli DF, Moslehi J, Roden DM. PMID: 29563327; PMCID: PMC5931436.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    176. Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment. Curr Treat Options Cardiovasc Med. 2018 Mar 20; 20(4):31. Spetz J, Moslehi J, Sarosiek K. PMID: 29556748; PMCID: PMC7325164.
      View in: PubMed   Mentions: 34  
    177. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. J Am Coll Cardiol. 2018 04 24; 71(16):1755-1764. Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Lawrence DP, Groarke JD, Neilan TG. PMID: 29567210; PMCID: PMC6196725.
      View in: PubMed   Mentions: 574     Fields:    Translation:Humans
    178. Comorbidities: Cardiovascular disease and breast cancer. Nat Rev Cardiol. 2018 03 13; 15(4):200-202. Moey M, Moslehi J. PMID: 29532794.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    179. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet. 2018 03 10; 391(10124):933. Moslehi JJ, Salem JE, Sosman JA, Lebrun-Vignes B, Johnson DB. PMID: 29536852; PMCID: PMC6668330.
      View in: PubMed   Mentions: 353     Fields:    Translation:Humans
    180. Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. Hypertension. 2018 02; 71(2):e1-e8. Pandey AK, Singhi EK, Arroyo JP, Ikizler TA, Gould ER, Brown J, Beckman JA, Harrison DG, Moslehi J. PMID: 29279311; PMCID: PMC5825002.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimalsCells
    181. Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):110-114. Barber MC, Mauro MJ, Moslehi J. PMID: 29222244; PMCID: PMC6142546.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    182. The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases. Clin Genitourin Cancer. 2018 04; 16(2):e327-e333. Viteri Malone MA, Ares GR, De Velasco G, Brandão R, Lin X, Norton C, Simantov R, Moslehi J, Krajewski KM, Choueiri TK, McKay RR. PMID: 29361425.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    183. Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer. 2017 11 21; 5(1):91. Norwood TG, Westbrook BC, Johnson DB, Litovsky SH, Terry NL, McKee SB, Gertler AS, Moslehi JJ, Conry RM. PMID: 29157297; PMCID: PMC5697345.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    184. Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. Br J Haematol. 2018 01; 180(2):271-275. Fradley MG, Groarke JD, Laubach J, Alsina M, Lenihan DJ, Cornell RF, Maglio M, Shain KH, Richardson PG, Moslehi J. PMID: 29048105.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    185. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 09; 15(9):1140-1163. Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum TS, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, Freedman-Cass DA, McMillian NR. PMID: 28874599; PMCID: PMC5865602.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    186. Loss of the melanocortin-4 receptor in mice causes dilated cardiomyopathy. Elife. 2017 08 22; 6. Litt MJ, Okoye GD, Lark D, Cakir I, Moore C, Barber MC, Atkinson J, Fessel J, Moslehi J, Cone RD. PMID: 28829041; PMCID: PMC5577919.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    187. Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials. Haematologica. 2017 10; 102(10):1796-1805. Brown JR, Moslehi J, O'Brien S, Ghia P, Hillmen P, Cymbalista F, Shanafelt TD, Fraser G, Rule S, Kipps TJ, Coutre S, Dilhuydy MS, Cramer P, Tedeschi A, Jaeger U, Dreyling M, Byrd JC, Howes A, Todd M, Vermeulen J, James DF, Clow F, Styles L, Valentino R, Wildgust M, Mahler M, Burger JA. PMID: 28751558; PMCID: PMC5622864.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    188. Grounding Cardio-Oncology in Basic and Clinical Science. Circulation. 2017 07 04; 136(1):3-5. Moslehi J, Amgalan D, Kitsis RN. PMID: 28674089; PMCID: PMC5535811.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    189. Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A Review. JAMA Oncol. 2017 Jul 01; 3(7):980-988. Li W, Garcia D, Cornell RF, Gailani D, Laubach J, Maglio ME, Richardson PG, Moslehi J. PMID: 27632640.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    190. Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies. Curr Hematol Malig Rep. 2017 06; 12(3):257-267. Sethi TK, Basdag B, Bhatia N, Moslehi J, Reddy NM. PMID: 28233150.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    191. A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. Br J Haematol. 2017 08; 178(4):547-560. Laubach JP, Moslehi JJ, Francis SA, San Miguel JF, Sonneveld P, Orlowski RZ, Moreau P, Rosiñol L, Faber EA, Voorhees P, Mateos MV, Marquez L, Feng H, Desai A, van de Velde H, Elliott J, Shi H, Dow E, Jobanputra N, Esseltine DL, Niculescu L, Anderson KC, Lonial S, Richardson PG. PMID: 28466536; PMCID: PMC6812508.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    192. Cardio-Oncology: Vascular Endothelial Growth Factor Inhibitors, Salt, and Macrophages: A Complicated Interaction. Hypertension. 2017 05; 69(5):785-786. Moslehi J, Pandey AK, Bhatia N. PMID: 28320853.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    193. Cardiovascular Toxicities Associated with Cancer Immunotherapies. Curr Cardiol Rep. 2017 03; 19(3):21. Wang DY, Okoye GD, Neilan TG, Johnson DB, Moslehi JJ. PMID: 28220466; PMCID: PMC10176498.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    194. Cardio-Oncology: Time to Get More Mechanistic. JACC Basic Transl Sci. 2017 Feb; 2(1):54-55. Moslehi J, Lenihan DJ. PMID: 30167554; PMCID: PMC6113550.
      View in: PubMed   Mentions:
    195. Ventricular arrhythmias and sudden death in patients taking ibrutinib. Blood. 2017 05 04; 129(18):2581-2584. Lampson BL, Yu L, Glynn RJ, Barrientos JC, Jacobsen ED, Banerji V, Jones JA, Walewska R, Savage KJ, Michaud GF, Moslehi JJ, Brown JR. PMID: 28223277; PMCID: PMC7219062.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    196. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci Transl Med. 2017 02 15; 9(377). Sharma A, Burridge PW, McKeithan WL, Serrano R, Shukla P, Sayed N, Churko JM, Kitani T, Wu H, Holmström A, Matsa E, Zhang Y, Kumar A, Fan AC, Del Álamo JC, Wu SM, Moslehi JJ, Mercola M, Wu JC. PMID: 28202772; PMCID: PMC5409837.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansCells
    197. Myocarditis with Immune Checkpoint Blockade. N Engl J Med. 2017 01 19; 376(3):292. Moslehi JJ, Johnson DB, Sosman JA. PMID: 28099832.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    198. Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics. Cancer Cell. 2017 01 09; 31(1):142-156. Sarosiek KA, Fraser C, Muthalagu N, Bhola PD, Chang W, McBrayer SK, Cantlon A, Fisch S, Golomb-Mello G, Ryan JA, Deng J, Jian B, Corbett C, Goldenberg M, Madsen JR, Liao R, Walsh D, Sedivy J, Murphy DJ, Carrasco DR, Robinson S, Moslehi J, Letai A. PMID: 28017613; PMCID: PMC5363285.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansAnimalsCells
    199. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017 Mar 10; 35(8):893-911. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D. PMID: 27918725.
      View in: PubMed   Mentions: 459     Fields:    Translation:Humans
    200. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med. 2016 Nov 03; 375(18):1749-1755. Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA, Anders RA, Sosman JA, Moslehi JJ. PMID: 27806233; PMCID: PMC5247797.
      View in: PubMed   Mentions: 899     Fields:    Translation:Humans
    201. Cardiovascular Toxic Effects of Targeted Cancer Therapies. N Engl J Med. 2016 Oct 13; 375(15):1457-1467. Moslehi JJ. PMID: 27732808.
      View in: PubMed   Mentions: 248     Fields:    Translation:HumansCells
    202. 21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine. JACC Basic Transl Sci. 2016 Aug; 1(5):386-398. Sheng CC, Amiri-Kordestani L, Palmby T, Force T, Hong CC, Wu JC, Croce K, Kim G, Moslehi J. PMID: 28713868; PMCID: PMC5508213.
      View in: PubMed   Mentions: 22  
    203. NCCN Guidelines Insights: Survivorship, Version 1.2016. J Natl Compr Canc Netw. 2016 06; 14(6):715-24. Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. PMID: 27283164; PMCID: PMC5865597.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    204. Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment. Oncologist. 2016 06; 21(6):666-70. Truong SR, Barry WT, Moslehi JJ, Baker EL, Mayer EL, Partridge AH. PMID: 27107002; PMCID: PMC4912366.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    205. EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection. Cell. 2016 Apr 07; 165(2):497. Olenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG. PMID: 27058668.
      View in: PubMed   Mentions: 15     Fields:    
    206. Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty. J Card Fail. 2016 Jun; 22(6):465-71. Lenihan DJ, Hartlage G, DeCara J, Blaes A, Finet JE, Lyon AR, Cornell RF, Moslehi J, Oliveira GH, Murtagh G, Fisch M, Zeevi G, Iakobishvili Z, Witteles R, Patel A, Harrison E, Fradley M, Curigliano G, Lenneman CG, Magalhaes A, Krone R, Porter C, Parasher S, Dent S, Douglas P, Carver J. PMID: 27038642.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    207. Cardiovascular Complications of Novel Multiple Myeloma Treatments. Circulation. 2016 Mar 01; 133(9):908-12. Li W, Cornell RF, Lenihan D, Slosky D, Jagasia M, Piazza G, Moslehi J. PMID: 26927008.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    208. EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection. Cell. 2016 Feb 25; 164(5):884-95. Olenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG. PMID: 26919427; PMCID: PMC4819986.
      View in: PubMed   Mentions: 59     Fields:    Translation:Animals
    209. Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer. Circulation. 2016 Feb 02; 133(5):537-41. Bhatia N, Santos M, Jones LW, Beckman JA, Penson DF, Morgans AK, Moslehi J. PMID: 26831435; PMCID: PMC5029929.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    210. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA Oncol. 2016 Jan; 2(1):29-36. Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, Krop I, Burstein HJ, Hudis C, Winer EP, Tolaney SM. PMID: 26539793; PMCID: PMC5654518.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    211. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery. Circulation. 2015 Dec 08; 132(23):2248-58. Bellinger AM, Arteaga CL, Force T, Humphreys BD, Demetri GD, Druker BJ, Moslehi JJ. PMID: 26644247; PMCID: PMC4863699.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimals
    212. Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training. Crit Rev Oncol Hematol. 2016 Feb; 98:222-34. Scott JM, Armenian S, Giralt S, Moslehi J, Wang T, Jones LW. PMID: 26643524; PMCID: PMC5003053.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    213. Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis. Circulation. 2015 Nov 03; 132(18):e218-20. Guan J, Khambhati J, Jones LW, Morgans A, Allaf M, Penson DF, Moslehi J. PMID: 26527696; PMCID: PMC5004633.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    214. Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia. J Clin Oncol. 2015 Dec 10; 33(35):4210-8. Moslehi JJ, Deininger M. PMID: 26371140; PMCID: PMC4658454.
      View in: PubMed   Mentions: 173     Fields:    Translation:Humans
    215. Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors. J Am Coll Cardiol. 2015 Sep 08; 66(10):1160-78. Li W, Croce K, Steensma DP, McDermott DF, Ben-Yehuda O, Moslehi J. PMID: 26337996.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimals
    216. QT Prolongation and Oncology Drug Development. Card Electrophysiol Clin. 2015 Jun; 7(2):341-55. Fradley MG, Moslehi J. PMID: 26002398.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    217. Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes. J Am Coll Cardiol. 2015 Feb 17; 65(6):573-83. Groarke JD, Tanguturi VK, Hainer J, Klein J, Moslehi JJ, Ng A, Forman DE, Di Carli MF, Nohria A. PMID: 25677317.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    218. Survivorship: screening for cancer and treatment effects, version 2.2014. J Natl Compr Canc Netw. 2014 Nov; 12(11):1526-31. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. PMID: 25361799; PMCID: PMC4771020.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    219. ABCDE steps to prevent heart disease in breast cancer survivors. Circulation. 2014 Oct 28; 130(18):e157-9. Montazeri K, Unitt C, Foody JM, Harris JR, Partridge AH, Moslehi J. PMID: 25462826.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    220. Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1396-406. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA, National Comprehensive Cancer Network. PMID: 25313179; PMCID: PMC4465236.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    221. Unravelling the causes of reduced peak oxygen consumption in patients with cancer: complex, timely, and necessary. J Am Coll Cardiol. 2014 Sep 30; 64(13):1320-2. Koelwyn GJ, Jones LW, Moslehi J. PMID: 25257632.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    222. Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway. Curr Treat Options Cardiovasc Med. 2014 Sep; 16(9):335. Groarke JD, Choueiri TK, Slosky D, Cheng S, Moslehi J. PMID: 25099086.
      View in: PubMed   Mentions: 15  
    223. Survivorship: healthy lifestyles, version 2.2014. J Natl Compr Canc Netw. 2014 Sep; 12(9):1222-37. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA, National comprehensive cancer network. PMID: 25190692; PMCID: PMC4465248.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    224. Survivorship: immunizations and prevention of infections, version 2.2014. J Natl Compr Canc Netw. 2014 Aug; 12(8):1098-111. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. PMID: 25099442; PMCID: PMC4465238.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    225. The challenge of cross-trial comparisons using limited data. Haematologica. 2014 Aug; 99(8):e145-6. Laubach JP, Faber EA, Voorhees P, Moslehi J, Varga C, Niculescu L, Anderson KC, Richardson PG. PMID: 25082787; PMCID: PMC4116848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    226. Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase. Genes Dev. 2014 Jul 01; 28(13):1429-44. Zheng X, Zhai B, Koivunen P, Shin SJ, Lu G, Liu J, Geisen C, Chakraborty AA, Moslehi JJ, Smalley DM, Wei X, Chen X, Chen Z, Beres JM, Zhang J, Tsao JL, Brenner MC, Zhang Y, Fan C, DePinho RA, Paik J, Gygi SP, Kaelin WG, Zhang Q. PMID: 24990963; PMCID: PMC4083087.
      View in: PubMed   Mentions: 76     Fields:    Translation:AnimalsCells
    227. Survivorship: cognitive function, version 1.2014. J Natl Compr Canc Netw. 2014 Jul; 12(7):976-86. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA, National Comprehensive Cancer Network. PMID: 24994918; PMCID: PMC4465252.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    228. Cardiology patient page. Breast cancer chemotherapy and your heart. Circulation. 2014 Jun 24; 129(25):e680-2. Unitt C, Montazeri K, Tolaney S, Moslehi J. PMID: 24958758.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    229. Survivorship: fatigue, version 1.2014. J Natl Compr Canc Netw. 2014 Jun; 12(6):876-87. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. PMID: 24925198; PMCID: PMC4465265.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    230. Survivorship: sleep disorders, version 1.2014. J Natl Compr Canc Netw. 2014 May; 12(5):630-42. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D, National Comprehensive Cancer Network. PMID: 24812132; PMCID: PMC4771023.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    231. Survivorship: pain version 1.2014. J Natl Compr Canc Netw. 2014 Apr; 12(4):488-500. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D, National Comprehensive Cancer Network. PMID: 24717568; PMCID: PMC4465256.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    232. D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice. Genes Dev. 2014 Mar 01; 28(5):479-90. Akbay EA, Moslehi J, Christensen CL, Saha S, Tchaicha JH, Ramkissoon SH, Stewart KM, Carretero J, Kikuchi E, Zhang H, Cohoon TJ, Murray S, Liu W, Uno K, Fisch S, Jones K, Gurumurthy S, Gliser C, Choe S, Keenan M, Son J, Stanley I, Losman JA, Padera R, Bronson RT, Asara JM, Abdel-Wahab O, Amrein PC, Fathi AT, Danial NN, Kimmelman AC, Kung AL, Ligon KL, Yen KE, Kaelin WG, Bardeesy N, Wong KK. PMID: 24589777; PMCID: PMC3950345.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    233. Heart failure and breast cancer therapies: moving towards personalized risk assessment. J Am Heart Assoc. 2014 Feb 28; 3(1):e000780. Francis SA, Cheng S, Arteaga CL, Moslehi J. PMID: 24584746; PMCID: PMC3959702.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    234. Real-time three-dimensional transoesophageal echocardiography enables preoperative pulmonary valvulopathy assessment. Eur Heart J Cardiovasc Imaging. 2014 Jun; 15(6):713. Waller AH, Chatzizisis YS, Moslehi JJ, Chen FY, Mangion JR. PMID: 24378480.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    235. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013 Dec 19; 155(7):1624-38. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA. PMID: 24360282; PMCID: PMC4076149.
      View in: PubMed   Mentions: 660     Fields:    Translation:AnimalsCells
    236. Cancer-drug discovery and cardiovascular surveillance. N Engl J Med. 2013 Nov 07; 369(19):1779-81. Groarke JD, Cheng S, Moslehi J. PMID: 24180496.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    237. A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2014 Jan; 25(1):81-91. Liu D, Wang CJ, Judge DP, Halushka MK, Ni J, Habashi JP, Moslehi J, Bedja D, Gabrielson KL, Xu H, Qian F, Huso D, Dietz HC, Germino GG, Watnick T. PMID: 24071006; PMCID: PMC3871766.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    238. MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ Res. 2013 Nov 08; 113(11):1231-41. Icli B, Wara AK, Moslehi J, Sun X, Plovie E, Cahill M, Marchini JF, Schissler A, Padera RF, Shi J, Cheng HW, Raghuram S, Arany Z, Liao R, Croce K, MacRae C, Feinberg MW. PMID: 24047927; PMCID: PMC4068743.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansAnimalsCells
    239. Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res. 2013 Aug 30; 113(6):754-64. Ky B, Vejpongsa P, Yeh ET, Force T, Moslehi JJ. PMID: 23989717; PMCID: PMC4046703.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansAnimals
    240. Cardio-oncology: it takes two to translate. Sci Transl Med. 2013 May 29; 5(187):187fs20. Moslehi J, Cheng S. PMID: 23720578.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    241. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J. 2014 Mar; 35(10):612-23. Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J. PMID: 23666251; PMCID: PMC3945797.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansPHPublic Health
    242. The cardiovascular perils of cancer survivorship. N Engl J Med. 2013 Mar 14; 368(11):1055-6. Moslehi J. PMID: 23484833.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    243. Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives. Trends Cardiovasc Med. 2013 May; 23(4):104-13. Bair SM, Choueiri TK, Moslehi J. PMID: 23290365; PMCID: PMC3621011.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    244. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013 Mar 01; 111(5):717-22. Neilan TG, Coelho-Filho OR, Shah RV, Feng JH, Pena-Herrera D, Mandry D, Pierre-Mongeon F, Heydari B, Francis SA, Moslehi J, Kwong RY, Jerosch-Herold M. PMID: 23228924; PMCID: PMC3578020.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    245. Breast cancer therapies and cardiomyopathy. Med Clin North Am. 2012 Sep; 96(5):1001-19. Groarke J, Tong D, Khambhati J, Cheng S, Moslehi J. PMID: 22980061; PMCID: PMC10331631.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    246. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol. 2012 Dec 01; 110(11):1679-86. Neilan TG, Coelho-Filho OR, Pena-Herrera D, Shah RV, Jerosch-Herold M, Francis SA, Moslehi J, Kwong RY. PMID: 22917553; PMCID: PMC3496816.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    247. Management of antiangiogenic therapy-induced hypertension. Hypertension. 2012 Sep; 60(3):607-15. de Jesus-Gonzalez N, Robinson E, Moslehi J, Humphreys BD. PMID: 22851729; PMCID: PMC3421063.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    248. Treatment of erythropoietin deficiency in mice with systemically administered siRNA. Blood. 2012 Aug 30; 120(9):1916-22. Querbes W, Bogorad RL, Moslehi J, Wong J, Chan AY, Bulgakova E, Kuchimanchi S, Akinc A, Fitzgerald K, Koteliansky V, Kaelin WG. PMID: 22611156; PMCID: PMC3433093.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    249. Telomeres and mitochondria in the aging heart. Circ Res. 2012 Apr 27; 110(9):1226-37. Moslehi J, DePinho RA, Sahin E. PMID: 22539756; PMCID: PMC3718635.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    250. You can't run from inflammation: lower extremity ischemia, hypoxia signaling, and macrophage subtypes. Circ Res. 2012 Apr 13; 110(8):1045-6. Moslehi J, Libby P. PMID: 22499897.
      View in: PubMed   Mentions: 4     Fields:    
    251. Reversible cardiomyopathy associated with sunitinib and sorafenib. N Engl J Med. 2011 Oct 27; 365(17):1649-50. Uraizee I, Cheng S, Moslehi J. PMID: 22030001.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    252. Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension. Circulation. 2011 Oct 11; 124(15):1687-91. Nazer B, Humphreys BD, Moslehi J. PMID: 21986775.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    253. Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib. J Clin Oncol. 2011 Sep 01; 29(25):3450-6. Richards CJ, Je Y, Schutz FA, Heng DY, Dallabrida SM, Moslehi JJ, Choueiri TK. PMID: 21810682.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    254. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011 Feb 17; 470(7334):359-65. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. PMID: 21307849; PMCID: PMC3741661.
      View in: PubMed   Mentions: 620     Fields:    Translation:AnimalsCells
    255. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation. 2010 Sep 07; 122(10):1004-16. Moslehi J, Minamishima YA, Shi J, Neuberg D, Charytan DM, Padera RF, Signoretti S, Liao R, Kaelin WG. PMID: 20733101; PMCID: PMC2971656.
      View in: PubMed   Mentions: 80     Fields:    Translation:AnimalsCells
    256. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol. 2009 Nov; 29(21):5729-41. Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG. PMID: 19720742; PMCID: PMC2772748.
      View in: PubMed   Mentions: 80     Fields:    Translation:AnimalsCells
    257. Paragangliomas: etiology, presentation, and management. Cardiol Rev. 2009 Jul-Aug; 17(4):159-64. Joynt KE, Moslehi JJ, Baughman KL. PMID: 19525677.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    258. Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature. Am J Cardiol. 2008 Sep 01; 102(5):643-5. Sung AD, Cheng S, Moslehi J, Scully EP, Prior JM, Loscalzo J. PMID: 18721529.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    259. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood. 2008 Mar 15; 111(6):3236-44. Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG. PMID: 18096761; PMCID: PMC2265460.
      View in: PubMed   Mentions: 145     Fields:    Translation:AnimalsCells
    260. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism. Circ Res. 2005 Jan 07; 96(1):100-9. Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA. PMID: 15576651.
      View in: PubMed   Mentions: 87     Fields:    Translation:AnimalsCells
    261. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol Cell Biol. 2002 Mar; 22(6):1947-60. Hansen WJ, Ohh M, Moslehi J, Kondo K, Kaelin WG, Welch WJ. PMID: 11865071; PMCID: PMC135590.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    262. An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep. 2002 Feb; 3(2):177-82. Ohh M, Kim WY, Moslehi JJ, Chen Y, Chau V, Read MA, Kaelin WG. PMID: 11818338; PMCID: PMC1083969.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    263. Posterior urethral valves presented at birth despite normal prenatal ultrasound scans. Urology. 2001 Jun; 57(6):1178. Moslehi J, Herndon CD, McKenna PH. PMID: 11377342.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    264. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science. 2000 Aug 25; 289(5483):1317-21. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL. PMID: 10958771.
      View in: PubMed   Mentions: 347     Fields:    Translation:Cells
    265. Yeast prion [psi +] and its determinant, Sup35p. Methods Enzymol. 1999; 309:649-73. Serio TR, Cashikar AG, Moslehi JJ, Kowal AS, Lindquist SL. PMID: 10507053.
      View in: PubMed   Mentions: 52     Fields:    Translation:AnimalsCells
    266. Influence of antigen organization on the development of lupus autoantibodies. Arthritis Rheum. 1998 Apr; 41(4):603-12. Fatenejad S, Bennett M, Moslehi J, Craft J. PMID: 9550469.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    267. Perforin protects against autoimmunity in lupus-prone mice. J Immunol. 1998 Jan 15; 160(2):652-60. Peng SL, Moslehi J, Robert ME, Craft J. PMID: 9551899.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    268. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest. 1997 Apr 15; 99(8):1936-46. Peng SL, Moslehi J, Craft J. PMID: 9109438; PMCID: PMC508018.
      View in: PubMed   Mentions: 87     Fields:    Translation:Animals
    Javid's Networks
    Concepts (766)
    Derived automatically from this person's publications.
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _